Drug Database
Back to search

Netherlands· NL-3d8b7a6ec836

Medimibi 0,5 mg kit voor radiofarmaceutisch preparaat

A technetium (99mtc) sestamibi product containing koper(1+),tetrakis[1-isocyano-2-methoxy-2-methylpropyl]tetrafluorboraat, registered in Netherlands by Radiopharmacy Laboratory Ltd. The same ATC class is registered in 11 of our 19 countries.

ATC V09GA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMedimibi 0,5 mg kit voor radiofarmace…ATCV09GA01REGISTER NO.NL-3d8b7a6ec836PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about koper(1+),tetrakis[1-isocyano-2-methoxy-2-methylpropyl]tetrafluorboraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Technetium (99mtc) sestamibi is registered in 11 of 19 countries.

Countries holding a registration under ATC V09GA01 (technetium (99mtc) sestamibi), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search technetium (99mtc) sestamibi products by name

Technetium (99mtc) sestamibi · ATC V09GA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
KOPER(1+),TETRAKIS[1-ISOCYANO-2-METHOXY-2-METHYLPROPYL]TETRAFLUORBORAAT
Manufacturer
Radiopharmacy Laboratory Ltd
Country
Netherlands (NL)
ATC code
V09GA01
ATC class
Technetium (99mTc) sestamibi
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131842

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V09GA01

Technetium (99mtc) sestamibi, as other registers publish it.

All technetium (99mtc) sestamibi products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b11cc7a8-5e59-4f6a-9f42-79a324ba60df
GET /v1/drugs/b11cc7a8-5e59-4f6a-9f42-79a324ba60df?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit voor radiofarmaceutisch preparaat",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131842_smpc.pdf",
  "strength": null,
  "atc_label": "Technetium (99m Tc) Sestamibi",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131842",
  "excipients": [
    "CYSTEINE (L-)HYDROCHLORIDE 1-WATER (E 920)",
    "GLYCINE (E 640)",
    "NATRIUMCHLORIDE",
    "NATRIUMPYROFOSFAAT 10-WATER (E 450)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "TINDICHLORIDE 2-WATER (E 512)"
  ],
  "substances": [
    "KOPER(1+),TETRAKIS[1-ISOCYANO-2-METHOXY-2-METHYLPROPYL]TETRAFLUORBORAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131842.pdf",
  "authorised_at": "2024/07/22",
  "procedure_number": "DK/H/1193/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131842",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about technetium (99mtc) sestamibi.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console